Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin
about
Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.In Vivo Pharmacokinetic and Pharmacodynamic Profiles of Antofloxacin against Klebsiella pneumoniae in a Neutropenic Murine Lung Infection Model.In Vivo Bioluminescent Monitoring of Therapeutic Efficacy and Pharmacodynamic Target Assessment of Antofloxacin against Escherichia coli in a Neutropenic Murine Thigh Infection Model.
P2860
Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Wild-Type and Non-Wild-Type My ...... Levofloxacin, and Moxifloxacin
@en
Wild-Type and Non-Wild-Type My ...... evofloxacin, and Moxifloxacin.
@nl
type
label
Wild-Type and Non-Wild-Type My ...... Levofloxacin, and Moxifloxacin
@en
Wild-Type and Non-Wild-Type My ...... evofloxacin, and Moxifloxacin.
@nl
prefLabel
Wild-Type and Non-Wild-Type My ...... Levofloxacin, and Moxifloxacin
@en
Wild-Type and Non-Wild-Type My ...... evofloxacin, and Moxifloxacin.
@nl
P2093
P2860
P50
P356
P1476
Wild-Type and Non-Wild-Type My ...... Levofloxacin, and Moxifloxacin
@en
P2093
Guirong Wang
Guomei Wei
Hairong Huang
Lingling Dong
Suting Chen
Thomas Schön
Yuanyuan Shang
P2860
P304
P356
10.1128/AAC.00393-16
P407
P577
2016-06-20T00:00:00Z